Document is current
Any future updates will be listed below
-
Authors
Suzuki, Takayoshi
Ota, Yuka
Suzuki, Hisaharu
Hata, Seiichiro
Minami, Keiichiro
Bissen-Miyajima, Hiroko
-
Funding
Funding for this research was provided by:
Alcon Japan
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 17 October 2024
First Online: 28 October 2024
Declarations
:
: This investigator-initiated prospective study was approved by a local Certified Review Board (Shinanozaka Clinic/Hattori Clinic CRBs, Tokyo, Japan) and registered with the Japan Registry for Clinical Trials (identifier: jRCTs032220042). This study was conducted in accordance with the tenets of the Declaration of Helsinki and Clinical Trials Act of Japan (Act No. 16, 2017). Written informed consent was obtained from all the patients.
: Not applicable.
: All received research support from Alcon. HBM is consultant and speaker bureaus of Alcon. KM is an editorial board member of BMC Ophthalmology.
